KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for Fulgent Genetics (FLGT) over the last 3 years, with Q3 2025 value amounting to -$5000.0.

  • Fulgent Genetics' Other Non Operating Income fell 10091.91% to -$5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $116000.0, marking a year-over-year decrease of 7786.26%. This contributed to the annual value of $561000.0 for FY2024, which is 7531.25% up from last year.
  • Fulgent Genetics' Other Non Operating Income amounted to -$5000.0 in Q3 2025, which was down 10091.91% from $46000.0 recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Other Non Operating Income peaked at $544000.0 during Q3 2024, and registered a low of -$22000.0 during Q4 2023.
  • Moreover, its 3-year median value for Other Non Operating Income was $11000.0 (2024), whereas its average is $98222.2.
  • Over the last 5 years, Fulgent Genetics' Other Non Operating Income had its largest YoY gain of 85555.56% in 2025, and its largest YoY loss of 10091.91% in 2025.
  • Fulgent Genetics' Other Non Operating Income (Quarter) stood at -$22000.0 in 2023, then soared by 131.82% to $7000.0 in 2024, then plummeted by 171.43% to -$5000.0 in 2025.
  • Its last three reported values are -$5000.0 in Q3 2025, $46000.0 for Q2 2025, and $68000.0 during Q1 2025.